Howe & Rusling Inc Biogen Inc. Transaction History

Howe & Rusling Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $10,123 - $13,959	52 New	52 $14,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $5,698 - $9,123	-22 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $1,457 - $1,707	-6 Reduced 21.43%	22 $6,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $3,071 - $4,623	-13 Reduced 31.71%	28 $7,000
Q2 2020 Jul 15, 2020	SELL	$258.66 - $342.55 $2,586 - $3,425	-10 Reduced 19.61%	41 $11,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $2,150 - $2,728	-8 Reduced 13.56%	51 $16,000
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $3,520 - $4,865	-16 Reduced 21.33%	59 $18,000
Q3 2019 Oct 31, 2019	BUY	$217.44 - $243.88 $1,522 - $1,707	7 Added 10.29%	75 $17,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $1,096 - $1,208	-5 Reduced 6.85%	68 $16,000
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $1,300 - $2,033	-6 Reduced 7.59%	73 $17,000
Q4 2018 Feb 04, 2019	SELL	$278.5 - $352.75 $7,798 - $9,877	-28 Reduced 26.17%	79 $24,000
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $2,054 - $2,686	7 Added 7.0%	107 $38,000
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $10,558 - $12,583	-41 Reduced 29.08%	100 $29,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $137,088 - $193,888	-527 Reduced 78.89%	141 $39,000
Q4 2017 Jan 24, 2018	SELL	$307.64 - $344.58 $922 - $1,033	-3 Reduced 0.45%	668 $213,000
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $188,651 - $221,221	671	671 $210,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.